{ "ok": true, "cik": "1562733", "ticker": "SNYR", "name": "Synergy CHC Corp.", "filings": [ { "form": "8-K", "filed": "2026-09-16", "items": [ "3.01 Notice of Delisting or Failure to Satisfy a Listing Rule" ], "url": "https://www.sec.gov/Archives/edgar/data/1562733/000121390026100556/0001213900-26-100556-index.htm" }, { "form": "8-K", "filed": "2026-09-08", "items": [ "1.03 Bankruptcy or Receivership", "5.02 Departure or Election of Directors; Appointment of Officers" ], "url": "https://www.sec.gov/Archives/edgar/data/1562733/000121390026097802/0001213900-26-097802-index.htm" }, { "form": "8-K", "filed": "2026-08-26", "items": [ "2.04 Triggering Events That Accelerate a Financial Obligation" ], "url": "https://www.sec.gov/Archives/edgar/data/1562733/000121390026093728/0001213900-26-093728-index.htm" }, { "form": "8-K", "filed": "2026-08-21", "items": [ "3.01 Notice of Delisting or Failure to Satisfy a Listing Rule", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1562733/000121390026092335/0001213900-26-092335-index.htm" }, { "form": "8-K", "filed": "2026-08-11", "items": [ "2.04 Triggering Events That Accelerate a Financial Obligation" ], "url": "https://www.sec.gov/Archives/edgar/data/1562733/000121390026087826/0001213900-26-087826-index.htm" }, { "form": "8-K", "filed": "2026-07-29", "items": [ "8.01 Other Events" ], "url": "https://www.sec.gov/Archives/edgar/data/1562733/000121390026082791/0001213900-26-082791-index.htm" } ], "events12m": 14, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001562733.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1562733" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets, no buy or sell views.", "edgar": "🫧 Edgar looked up Synergy CHC Corp. ($SNYR). Last filing: 8-K (3.01 Notice of Delisting or Failure to Satisfy a Listing Rule), 2026-09-16. 14 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 30380809, "revenueGrowth1y": -0.1278464412159036, "revenueGrowthPerYear": -0.015220637132401293, "yearsOfData": 5, "operatingMargin": -0.2784240867318576, "operatingMarginPrior": 0.1665386556555858, "netMargin": -0.4062172274609277, "operatingCashFlow": -2585022, "capitalSpending": null, "freeCashFlow": null, "researchAndDevelopment": null, "researchShareOfRevenue": null, "cash": 2622313, "longTermDebt": 25056446, "longTermDebtChange": 1.1869946658040806, "revenueHistory": [ { "fiscalYearEnd": "2018-12-31", "revenue": 33824495 }, { "fiscalYearEnd": "2019-12-31", "revenue": 29357546 }, { "fiscalYearEnd": "2023-12-31", "revenue": 42777633 }, { "fiscalYearEnd": "2024-12-31", "revenue": 34834243 }, { "fiscalYearEnd": "2025-12-31", "revenue": 30380809 } ], "totalEquity": -23128138, "totalAssets": 10164376, "equityRatio": -2.275411495993458, "returnOnEquity": null, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "range80": { "low": 20999261.468733586, "high": 37706535.99059425, "baseline": 28613246.312486153, "n": 749, "band": "b00" }, "ifPaceHeld": { "low": 20999261.468733586, "high": 37706535.99059425 } }, "edgarette": "🔖 Exposure: revenue $30.4M (FY2025), total debt $25.1M. Experience: revenue down 12.8% on the year, down 1.5% a year over 7 years; operating margin -27.8%, down from 16.7%. Soundness: equity -227.5% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $21.0M and $37.7M next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A range, not a forecast. Against peers (10 filers, $50M+ revenue, medicinal chemicals & botanical products): operating margin -27.8% against a 0.7% median; growth -12.8% against 1.7%.", "peers": { "sic": 2833, "sicDescription": "Medicinal Chemicals & Botanical Products", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2833", "growth": [ 0.0172, 10 ], "opMargin": [ 0.0073, 10 ], "equityRatio": [ 0.3327, 8 ] }, "summary": "Synergy CHC (SNYR) saw revenue fall 12.8% in FY2025 to $30 million, operating margin -27.8% against a 0.7% median for medicinal chemicals & botanical products, equity -228% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
Synergy CHC Corp. against its own record and its peers
Operating marginPeer median 0.7%-27.8%Revenue, on the yearPeer median 1.7%-12.8%Equity of assetsPeer median 33.3%-227.5%Gold tick: the median of 8–8 peers with $50M+ revenue in medicinal chemicals & botanical products
", "chartHorizon": null, "backtest": { "tests": 4, "hits": 2, "rate": 0.5, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-20T15:22:32.664Z", "hash": "7aef923d9c51645d", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Synergy CHC (SNYR) saw revenue fall 12.8% in FY2025 to $30 million, operating margin -27.8% against a 0.7% median for medicinal chemicals & botanical products, equity -228% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 30380809, "totalDebt": 25056446, "cash": 2622313 }, "experience": { "revenueGrowth1y": -0.1278464412159036, "revenueGrowthPerYear": -0.015220637132401293, "operatingMargin": -0.2784240867318576, "operatingMarginPrior": 0.1665386556555858, "netMargin": -0.4062172274609277, "freeCashFlow": null }, "soundness": { "equityRatio": -2.275411495993458, "returnOnEquity": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 2833, "sicDescription": "Medicinal Chemicals & Botanical Products", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2833", "growth": [ 0.0172, 10 ], "opMargin": [ 0.0073, 10 ], "equityRatio": [ 0.3327, 8 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "range": { "low": 20999261.468733586, "high": 37706535.99059425, "baseline": 28613246.312486153, "coverage": 0.8, "method": "v3", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); range = 10th to 90th percentile of how SEC company-years of the same size band actually turned out", "calibratedOn": { "companyYears": 749, "sizeBand": "b00" }, "kind": "a calibrated range, not a forecast; no view on the share price", "track": { "backtest": { "tests": 4, "hits": 2, "rate": 0.5, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-20T15:22:32.664Z", "hash": "7aef923d9c51645d", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001562733.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1562733" } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same if-the-pace-held arithmetic applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so." } }